Safe and effective treatment with daclatasvir and asunaprevir in a liver transplant recipient with severe cholestatic hepatitis C
Author:
Affiliation:
1. Department of Gastroenterology and Hepatology; Kyoto Japan
2. Surgery, Graduate School of Medicine; Kyoto University; Kyoto Japan
Publisher
Wiley
Subject
Infectious Diseases,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12509/fullpdf
Reference7 articles.
1. Post-liver transplant cholestatic hepatitis C: a systematic review of clinical and pathological findings and application of consensus criteria;Narang;Liver Transpl,2010 Nov
2. Liver transplantation in the setting of chronic HCV;Terrault;Best Pract Res Clin Gastroenterol,2012 Aug
3. Interferon alpha 2B and ribavirin in severe recurrent cholestatic hepatitis C;Ong;Transplantation,2001 May 27
4. Sofosbuvir and daclatasvir combination therapy in a liver transplant recipient with severe recurrent cholestatic hepatitis C;Fontana;Am J Transplant,2013 Jun
5. Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection;Kumada;Hepatology,2014 Jun
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effects of dual plasma molecular adsorption system on liver function, electrolytes, inflammation, and immunity in patients with chronic severe hepatitis;Journal of Clinical Laboratory Analysis;2019-06-17
2. Serum Asunaprevir and Daclatasvir Concentrations and Outcomes in Patients with Recurrent Hepatitis C Who Have Undergone Living Donor Liver Transplantation;Anticancer Research;2018-09
3. Three patients treated with sofosbuvir plus ledipasvir for recurrent hepatitis C after liver transplantation;Clinical Journal of Gastroenterology;2017-02-21
4. Outcomes of treatment with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation;Hepatology Research;2017-01-17
5. Validation of the FIB-4 index for evaluation of fibrosis in patients with recurrent hepatitis C after living donor liver transplantation: A single center experience;Hepatology Research;2015-12-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3